Intellia Therapeutics Hits Day High with 19.72% Surge in Stock Price

Intellia Therapeutics, Inc. has experienced significant movement in its stock today, achieving a notable gain of 19.72% as of October 8, 2025. The stock reached an intraday high of USD 26.45, reflecting a strong performance compared to the S&P 500, which saw a decline of 0.38% on the same day.
Over the past week, Intellia has shown impressive growth, with a 30.44% increase, while its monthly performance stands at an extraordinary 106.67%. Year-to-date, the stock has surged by 109.86%, significantly outperforming the S&P 500's 14.16% gain. However, it is important to note that the company has faced challenges in the long term, with a three-year performance decline of 56.32%.

Intellia operates within the Pharmaceuticals & Biotechnology sector, holding a market capitalization of USD 1,271 million. Despite today's gains, the company has reported negative operating cash flow and a return on equity of -65.26%, indicating ongoing financial pressures. Investors may want to consider these factors when evaluating the stock's overall performance and market position.